We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62B
AUM Growth
+$4.39B
Cap. Flow
-$1.97B
Cap. Flow %
-3.18%
Top 10 Hldgs %
43.7%
Holding
1,103
New
130
Increased
284
Reduced
500
Closed
130

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$218M
2
PH icon
Parker-Hannifin
PH
+$155M
3
ILMN icon
Illumina
ILMN
+$80.7M
4
DIS icon
Walt Disney
DIS
+$74.2M
5
AZEK
The AZEK Co
AZEK
+$56.4M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$819M
2
META icon
Meta Platforms (Facebook)
META
+$338M
3
MSFT icon
Microsoft
MSFT
+$131M
4
AMZN icon
Amazon
AMZN
+$106M
5
CRM icon
Salesforce
CRM
+$93.2M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Communication Services 16.35%
3 Consumer Discretionary 16.22%
4 Healthcare 12.62%
5 Financials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICFI icon
151
ICF International
ICFI
$1.72B
$35.6M 0.06%
286,226
+53,492
+23% +$6.17M
NOG icon
152
Northern Oil and Gas
NOG
$2.35B
$35.5M 0.06%
1,033,022
+49,743
+5% +$1.61M
AIR icon
153
AAR Corp
AIR
$5.76B
$35.2M 0.06%
608,969
+88,949
+17% +$4.8M
THRM icon
154
Gentherm
THRM
$1.27B
$34.9M 0.06%
617,146
-5,704
-0.9% -$329K
MRTN icon
155
Marten Transport
MRTN
$1.22B
$34.8M 0.06%
1,618,402
-15,000
-0.9% -$315K
UFPI icon
156
UFP Industries
UFPI
$5.19B
$34.7M 0.06%
357,967
+15,601
+5% +$1.3M
THC icon
157
Tenet Healthcare
THC
$21.1B
$34.7M 0.06%
425,908
+21,533
+5% +$1.53M
UAA icon
158
Under Armour
UAA
$2.6B
$34.6M 0.06%
4,794,488
-92,226
-2% -$742K
ONTO icon
159
Onto Innovation
ONTO
$15.3B
$34.6M 0.06%
+297,012
New +$28.3M
LIVN icon
160
LivaNova
LIVN
$4.2B
$34.5M 0.06%
670,985
-100,557
-13% -$4.72M
DRS icon
161
Leonardo DRS
DRS
$12B
$34.4M 0.06%
1,983,916
+100,047
+5% +$1.55M
TDW icon
162
Tidewater
TDW
$4.12B
$34.4M 0.06%
619,661
+223,051
+56% +$10.2M
INSM icon
163
Insmed
INSM
$28.6B
$34M 0.05%
1,613,596
-14,922
-0.9% -$283K
POWI icon
164
Power Integrations
POWI
$3.61B
$33.6M 0.05%
355,427
+49,912
+16% +$4.17M
PZZA icon
165
Papa John's
PZZA
$806M
$33.5M 0.05%
453,298
-4,175
-0.9% -$310K
MBUU icon
166
Malibu Boats
MBUU
$567M
$33.4M 0.05%
569,666
-5,264
-0.9% -$296K
EEFT icon
167
Euronet Worldwide
EEFT
$2.7B
$33.4M 0.05%
284,430
+11,804
+4% +$1.32M
VTYX
168
DELISTED
Ventyx Biosciences
VTYX
$32.7M 0.05%
+998,237
New +$34.4M
DORM icon
169
Dorman Products
DORM
$4.18B
$32.4M 0.05%
411,601
-3,811
-0.9% -$321K
TYL icon
170
Tyler Technologies
TYL
$12.8B
$32.3M 0.05%
77,543
+8,350
+12% +$3.22M
HOMB icon
171
Home BancShares
HOMB
$6.18B
$32.2M 0.05%
1,410,649
+76,278
+6% +$1.66M
OXM icon
172
Oxford Industries
OXM
$552M
$32.1M 0.05%
326,410
-3,017
-0.9% -$309K
NVMI
173
Nova
NVMI
$12.5B
$31.7M 0.05%
270,078
+12,829
+5% +$1.31M
TMCI icon
174
Treace Medical Concepts
TMCI
$309M
$31.6M 0.05%
1,235,914
+150,727
+14% +$3.89M
ATI icon
175
ATI
ATI
$31B
$31.5M 0.05%
711,064
+142,473
+25% +$5.45M

Similar funds

Loomis, Sayles & Company's Q2 2023 Portfolio in Review

As of Q2 2023, Loomis, Sayles & Company held 1,103 positions worth $62B, up 7.6% from $57.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Loomis, Sayles & Company withdrew a net $1.97B in Q2 2023, closing 130 positions and reducing 500 holdings. Its most notable exit was Halozyme, an estimated $81.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Loomis, Sayles & Company opened a new position in The AZEK Co worth $66.1M.

  • Loomis, Sayles & Company's largest Q2 2023 buy was The AZEK Co: 2,181,837 shares worth $66.1M.
  • Loomis, Sayles & Company added most to Tesla in Q2 2023, an estimated $218M increase.
  • Loomis, Sayles & Company's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $819M.
  • Loomis, Sayles & Company fully exited Halozyme in Q2 2023, selling an estimated $81.3M.
  • Loomis, Sayles & Company's ten largest holdings make up 44% of its $62B portfolio in Q2 2023.
  • Loomis, Sayles & Company opened 130 new positions and closed 130 in Q2 2023.
  • Loomis, Sayles & Company's portfolio value rose 7.6% quarter-over-quarter to $62B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.